Immunotherapy against lung cancer does not need to compromise the outcomes of COVID‐19
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2024-01-01
|
Series: | MedComm |
Online Access: | https://doi.org/10.1002/mco2.451 |